2.67
price up icon4.71%   0.12
after-market After Hours: 2.67
loading
Achieve Life Sciences Inc stock is traded at $2.67, with a volume of 540.96K. It is up +4.71% in the last 24 hours and up +18.14% over the past month. Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
See More
Previous Close:
$2.55
Open:
$2.59
24h Volume:
540.96K
Relative Volume:
0.66
Market Cap:
$92.61M
Revenue:
-
Net Income/Loss:
$-32.94M
P/E Ratio:
-2.4054
EPS:
-1.11
Net Cash Flow:
$-24.95M
1W Performance:
-2.20%
1M Performance:
+18.14%
6M Performance:
-17.59%
1Y Performance:
-45.84%
1-Day Range:
Value
$2.53
$2.71
1-Week Range:
Value
$2.53
$2.77
52-Week Range:
Value
$1.84
$5.31

Achieve Life Sciences Inc Stock (ACHV) Company Profile

Name
Name
Achieve Life Sciences Inc
Name
Phone
425-686-1500
Name
Address
22722 29TH DR. SE, SEATTLE, BC
Name
Employee
25
Name
Twitter
Name
Next Earnings Date
2025-03-11
Name
Latest SEC Filings
Name
ACHV's Discussions on Twitter

Compare ACHV with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ACHV
Achieve Life Sciences Inc
2.67 133.65M 0 -32.94M -24.95M -1.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.16 118.34B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
554.58 60.31B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
339.80 42.35B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
598.89 36.43B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.94 31.87B 3.81B -644.79M -669.77M -6.24

Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-14-24 Initiated Rodman & Renshaw Buy
Sep-27-24 Initiated Raymond James Strong Buy
May-10-23 Reiterated Maxim Group Buy
Jun-23-21 Initiated Oppenheimer Outperform

Achieve Life Sciences Inc Stock (ACHV) Latest News

pulisher
Jul 29, 2025

Can Traders Expect Breakout From Achieve Life Sciences Inc. This WeekStock Screener With Smart Filters Highlights Top Picks - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Achieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference - GlobeNewswire

Jul 29, 2025
pulisher
Jul 29, 2025

Achieve Life Sciences to Participate in BTIG Virtual Biotechnology Conference on July 29-30, 2025 - Quiver Quantitative

Jul 29, 2025
pulisher
Jul 29, 2025

Achieve Life Sciences Reveals Latest Progress on Revolutionary Smoking Cessation Drug at BTIG Biotech Conference - Stock Titan

Jul 29, 2025
pulisher
Jul 29, 2025

Why Achieve Life Sciences Inc. stock attracts strong analyst attentionRisk Adjusted Technical Entry Plan Gains Followers - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Momentum Screeners Rank Achieve Life Sciences Inc. in Top 5 TodayVerified Signal From Chart Patterns Detected - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-28 20:18:34 - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

How strong is Achieve Life Sciences Inc. company’s balance sheetAchieve consistent double-digit returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Market reaction to Achieve Life Sciences Inc.’s recent newsShort-Term Growth Watch with Signal Prediction - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Sector ETF performance correlation with Achieve Life Sciences Inc.Reversal Signal Prediction Based on Volume - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What are the latest earnings results for ReShape Lifesciences Inc.Achieve breakthrough profits with smart strategies - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is the dividend policy of Kezar Life Sciences Inc. stockAchieve exceptional returns with expert guidance - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Has Achieve Life Sciences Inc. found a price floor Loss Limitation Strategy Based on Analysis - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

How to forecast Achieve Life Sciences Inc. trends using time series Smart Entry Watchlist with Daily Analysis - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

How to forecast Achieve Life Sciences Inc. trends using time series Daily Equity Signal Strength Summary Report - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What are the technical indicators suggesting about Achieve Life Sciences Inc.AI Powered Tips For 2025 - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Does TriSalus Life Sciences Inc. stock perform well during market downturnsAchieve consistent profits with smart trading - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is Kezar Life Sciences Inc. stock overvalued or undervaluedAchieve breakthrough profits with expert advice - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

How Efficient Is Achieve Life Sciences Inc. at Controlling Operating CostsMomentum Swing Watchlist - metal.it

Jul 27, 2025
pulisher
Jul 27, 2025

What makes Achieve Life Sciences Inc. stock price move sharplyMassive stock growth - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How does ReShape Lifesciences Inc. generate profit in a changing economyAchieve impressive returns with smart timing - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are Achieve Life Sciences Inc. company’s key revenue driversGet high-impact stock recommendations now - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How does Achieve Life Sciences Inc. compare to its industry peersFastest return on investment - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is Achieve Life Sciences Inc. stock overvalued or undervaluedExceptional profit velocity - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Achieve Life Sciences Inc. Company’s Quarterly Earnings Growth: What the Numbers SayFree Access to Community with 300% Return - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

How Interest Rate Changes Impact Achieve Life Sciences Inc. Stock PerformanceLow Drawdown Trade Signals - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

New Product Launches: Will They Boost Achieve Life Sciences Inc. Stock in 2025Free Stock Trading Community - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Key External Factors That Drive Achieve Life Sciences Inc. Stock Price MovementsParabolic Move Ideas - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

What makes Achieve Life Sciences Inc. stock attractive to long term investorsTop Momentum Stock Pick - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

Achieve Life Sciences Inc. Stock Analysis and ForecastFree Market Dynamics Reports - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

What drives Achieve Life Sciences Inc. stock priceDouble-digit growth - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Achieve Life Sciences to Announce Second Quarter Financial - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

Achieve Life Sciences to Update Investors on Smoking Cessation Drug Progress in Q2 Earnings Call - Stock Titan

Jul 24, 2025
pulisher
Jul 23, 2025

Is Achieve Life Sciences Inc. a good long term investmentBreakneck growth rates - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Achieve Life Sciences Inc. stockStrong return on assets - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Will Achieve Life Sciences Inc. stock split in the near futureFree Stock Selection - Newser

Jul 22, 2025
pulisher
Jul 21, 2025

Achieve Life Sciences stock falls after pricing capital raise of $45M via securities offering - MSN

Jul 21, 2025

Achieve Life Sciences Inc Stock (ACHV) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Achieve Life Sciences Inc Stock (ACHV) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Stewart Richard Alistair
Chieve Executive Officer
Mar 17 '25
Buy
2.86
10,000
28,598
60,876
$77.55
price up icon 0.23%
$37.13
price down icon 0.25%
$105.20
price up icon 0.05%
$26.66
price down icon 0.34%
$110.05
price down icon 1.28%
biotechnology ONC
$299.85
price down icon 2.06%
Cap:     |  Volume (24h):